Literature DB >> 19501907

Reduced l-arginine transport and nitric oxide synthesis in human umbilical vein endothelial cells from intrauterine growth restriction pregnancies is not further altered by hypoxia.

P Casanello1, B Krause, E Torres, V Gallardo, M González, C Prieto, C Escudero, M Farías, L Sobrevia.   

Abstract

Intrauterine growth restriction (IUGR) is associated with chronic fetal hypoxia, altered placental vasodilatation and reduced endothelial nitric oxide synthase (eNOS) activity. In human umbilical vein endothelial cells (HUVEC) from pregnancies complicated with IUGR (IUGR cells) and in HUVEC from normal pregnancies (normal cells) cultured under hypoxia l-arginine transport is reduced; however, the mechanisms leading to this dysfunction are unknown. We studied hypoxia effect on l-arginine transport and human cationic amino acid transporters 1 (hCAT-1) expression, and the potential NO and protein kinase C alpha (PKCalpha) involvement. Normal or IUGR HUVEC monolayers were exposed (0-24h) to 5% O(2) (normoxia), and 1 or 2% O(2) (hypoxia). l-Arginine transport and hCAT-1 expression, phosphorylated and total PKCalpha or eNOS protein and mRNA expression were quantified. eNOS involvement was tested using a siRNA against eNOS (eNOS-siRNA) adenovirus. IUGR cells in normoxia or hypoxia, and normal cells in hypoxia exhibited reduced l-arginine transport, hCAT-1 expression, NO synthesis and eNOS phosphorylation at Serine(1177), effects reversed by calphostin C (PKC inhibitor) and S-nitroso-N-acetyl-l,d-penicillamine (SNAP, NO donor). However, N(G)-nitro-l-arginine methyl ester (l-NAME, NOS inhibitor) reduced hCAT-1 expression only in normal cells in normoxia. Increased Thr(638)-phosphorylated PKCalpha was exhibited by IUGR cells in normoxia or hypoxia and normal cells in hypoxia. The effects of hypoxia in normal cells were mimicked in eNOS-siRNA transduced cells; however, IUGR phenotype was unaltered by eNOS knockdown. Thus, IUGR- and hypoxia-reduced l-arginine transport could result from increased PKCalpha, but reduced eNOS activity leading to a lower hCAT-1 expression in HUVEC. In addition, IUGR endothelial cells are either not responsive or maximally affected by hypoxia. These mechanisms could be responsible for placental dysfunction in diseases where fetal endothelium is chronically exposed to hypoxia, such as IUGR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19501907     DOI: 10.1016/j.placenta.2009.04.010

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  15 in total

Review 1.  The feto-placental endothelium in pregnancy pathologies.

Authors:  Christian Wadsack; Gernot Desoye; Ursula Hiden
Journal:  Wien Med Wochenschr       Date:  2012-05

Review 2.  Role of interferon alpha in endothelial dysfunction: insights into endothelial nitric oxide synthase-related mechanisms.

Authors:  Joy N Jones Buie; Jim C Oates
Journal:  Am J Med Sci       Date:  2014-08       Impact factor: 2.378

Review 3.  Role of the fetoplacental endothelium in fetal growth restriction with abnormal umbilical artery Doppler velocimetry.

Authors:  Emily J Su
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

4.  Endothelial nitric-oxide synthase activation generates an inducible nitric-oxide synthase-like output of nitric oxide in inflamed endothelium.

Authors:  Jessica L Lowry; Viktor Brovkovych; Yongkang Zhang; Randal A Skidgel
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

5.  Peroxisome Proliferator-Activated Receptor -β/δ, -γ Agonists and Resveratrol Modulate Hypoxia Induced Changes in Nuclear Receptor Activators of Muscle Oxidative Metabolism.

Authors:  Timothy R H Regnault; Lin Zhao; Jacky S S Chiu; Stephanie K Gottheil; Allison Foran; Siu-Pok Yee
Journal:  PPAR Res       Date:  2010-11-24       Impact factor: 4.964

6.  Role of DNA methyltransferase 1 on the altered eNOS expression in human umbilical endothelium from intrauterine growth restricted fetuses.

Authors:  Bernardo J Krause; Paula M Costello; Ernesto Muñoz-Urrutia; Karen A Lillycrop; Mark A Hanson; Paola Casanello
Journal:  Epigenetics       Date:  2013-07-18       Impact factor: 4.528

7.  Hypoxia alters ocular drug transporter expression and activity in rat and calf models: implications for drug delivery.

Authors:  Rajendra S Kadam; Preveen Ramamoorthy; Daniel J LaFlamme; Timothy A McKinsey; Uday B Kompella
Journal:  Mol Pharm       Date:  2013-05-22       Impact factor: 4.939

Review 8.  Role of nitric oxide in placental vascular development and function.

Authors:  B J Krause; M A Hanson; P Casanello
Journal:  Placenta       Date:  2011-07-27       Impact factor: 3.481

9.  CpG signalling, H2A.Z/H3 acetylation and microRNA-mediated deferred self-attenuation orchestrate foetal NOS3 expression.

Authors:  Jan Postberg; Miriam Kanders; Sakeh Forcob; Rhea Willems; Valerie Orth; Kai Oliver Hensel; Patrick Philipp Weil; Stefan Wirth; Andreas Christoph Jenke
Journal:  Clin Epigenetics       Date:  2015-02-08       Impact factor: 6.551

10.  Dysregulated flow-mediated vasodilatation in the human placenta in fetal growth restriction.

Authors:  Sarah Jones; Helen Bischof; Ingrid Lang; Gernot Desoye; Sue L Greenwood; Edward D Johnstone; Mark Wareing; Colin P Sibley; Paul Brownbill
Journal:  J Physiol       Date:  2015-06-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.